KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2016 - 2026)

Bristol Myers Squibb has reported Total Non-Current Liabilities over the past 18 years, most recently at $61.5 billion for Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 12.74% to $61.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.5 billion through Mar 2026, down 12.74% year-over-year, with the annual reading at $66.5 billion for FY2025, 7.33% down from the prior year.
  • Total Non-Current Liabilities was $61.5 billion for Q1 2026 at Bristol Myers Squibb, down from $66.5 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $75.8 billion in Q1 2024 and troughed at $55.6 billion in Q2 2023.
  • The 5-year median for Total Non-Current Liabilities is $64.1 billion (2022), against an average of $65.0 billion.
  • Year-over-year, Total Non-Current Liabilities dropped 13.03% in 2023 and then soared 35.92% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $59.1 billion in 2022, then increased by 0.24% to $59.3 billion in 2023, then increased by 21.08% to $71.7 billion in 2024, then dropped by 7.33% to $66.5 billion in 2025, then decreased by 7.47% to $61.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Total Non-Current Liabilities are $61.5 billion (Q1 2026), $66.5 billion (Q4 2025), and $72.8 billion (Q3 2025).